Fig. 1From: Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studiesExposure to Mountain Cedar allergen by day at each center prior to and during a Phase 2 and b Phase 3 trials. Data points are means of multiple measurements per centerBack to article page